Denmark to Stop Ozempic Patients Getting Decades-Worth of Drugs

Novo Nordisk A/S’s home country is set to cap how much Ozempic pharmacies are allowed to hand out to a single patient in a bid to halt the illegal resale of the popular drug.

The move comes after several patients in Denmark were prescribed large quantities of the subsidized diabetes medicine and resold it on the black market, where it is in high demand due to its effectiveness for weight loss. One patient was able to obtain a 27-year supply of Ozempic in just 11 months, receiving public reimbursements worth more than $57,600, Jyllands-Posten reported.

Danish health authorities ...